NEOBRAIN brings together small and medium sized enterprises (SMEs), industry and academic groups devoted to the diagnosis, management, and neuroprotection in newborns with perinatal brain damage. The focus of NEOBRAIN is to identify strategies prevention of brain damage mainly observed in preterm newborns. (Copy from www.neobrain.eu)
Study Type
OBSERVATIONAL
Enrollment
600
Medizinische Universität Innsbruck
Innsbruck, Austria
Hôpital Robert Debré
Paris, France
Charité, Campus Virchow Klinikum
Berlin, Germany
Brain white matter damage (WMD, defined by MRI ,US, EEG)
Time frame: during stay in NICU and until discharge
Developmental assessment
Time frame: at 2 years of age
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Universität Duisburg-Essen
Essen, Germany
Hannover Medical School
Hanover, Germany
Fondazione I.R.C.C.S Ospedale Maggiore Policlinico MA.RE.
Milan, Italy
Azienda Ospedaliera Universitaria Senese
Siena, Italy
Wilhelmina Children's Hospital
Utrecht, Netherlands
Perinatal Center
Gothenburg, Sweden
University Hospital
Lund, Sweden
...and 2 more locations